DJ AstraZeneca PLC ADR Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ advanced 2.55% to $71.71 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.55% to 17,461.32 and the Dow Jones Industrial Average rising 0.75% to 40,527.62.
This was the ADR's sixth consecutive day of gains.
AstraZeneca PLC ADR closed 18.21% below its 52-week high of $87.68, which the company achieved on August 30th.
The ADR outperformed some of its competitors Tuesday, as Eli Lilly & Co. $(LLY)$ rose 0.90% to $885.20, Biogen Inc. $(BIIB)$ rose 0.88% to $120.17, and Johnson & Johnson $(JNJ)$ rose 0.36% to $155.91.
Trading volume (7.9 M) eclipsed its 50-day average volume of 6.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 29, 2025 17:23 ET (21:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。